Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River announced a multi-year drug discovery collaboration with Takeda Pharmaceutical.
read more
Charleston Laboratories and Daiichi Sankyo have announced that a third Phase 3 clinical trial of CL-108, an opioid-containing formulation, met its primary endpoints.
read more
Wednesday, December 12, 2012
The Almac Group’s Clinical Technologies business unit is pleased to announce that Charlie Morris has joined the company as Vice President of New Products and Services. In this role, Mr. Morris will report directly to Jim Murphy, President of Almac ...
read more
Chartwell Pharmaceuticals has implemented software from Adents a provider of deployable serialization and track-and-trace software solutions for compliance with current and future track & trace deadlines.
read more
Check-Cap and GE Healthcare announced the companies have achieved the initial milestone in their collaboration to develop high-volume, X-ray capsule manufacturing capabilities.
read more
Tuesday, December 05, 2017
Check-Cap has entered the next phase of its manufacturing collaboration with GE Healthcare.
read more
Monday, December 30, 2019
Check-Cap announced positive results from the Company's pilot study of the C-Scan® System in the U.S.
read more
Friday, December 20, 2013
Following a successful inspection by the German health authorities in July 2013 ChemCon received the approval required to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use. This was an important step for the ...
read more
ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its customer Cristal Therapeutics, a privately-held life sciences ...
read more
Thursday, January 12, 2017
ChemDiv, Inc., a global research organization, announced achieving several key milestones in collaboration with Abbott's branded generics pharmaceutical business. The collaboration, begun in 2012 and expanded in 2015, is aimed at development and ...
read more
Wednesday, November 15, 2017
ChemDiv has entered into a three-way co-development agreement with Context Therapeutics and Torrey Pines Investment to advance research and development in the area of Sigma1 dysfunction.
read more
Chemic Laboratories Inc. and ASI today announced
establishment of a formal three year Joint Cooperation Agreement that will enable the two firms
to collaborate on a variety of Pharmaceutical and Biopharmaceutical client interests, primarily in
the...
read more
Chemomab Therapeutics,Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, and AGC Biologics, a global Biopharmaceutical Contract Development ...
read more
-- 100 Contract Research and Contract Manufacturing Organizations will be exhibiting at this year's September 17-19, 2013 Pharma ChemOutsourcing Show at the Jersey Shore reported Apaporis LLC, the organizer. The companies offer a wide range of ...
read more
Wednesday, August 20, 2025
ChemPartner announced its strategic expansion in the U.S. with the upcoming opening of the ChemPartner Boston Center of Excellence in Watertown, MA. The new R&D site will commence operations on September 10, 2025, providing discovery and preclinical ...
read more